WS #15034

Geopolitical tensions in the Middle East have escalated sharply following the US rejection of an Iranian ceasefire proposal, driving Brent crude toward $100 and triggering a broad risk-off response in global equities. The Dow Jones fell over 300 points, with the Fear & Greed Index dropping to 34, reflecting deepening investor anxiety over Strait of Hormuz stability. While the narrative of escalation remains dominant, the market is now pricing in the potential for prolonged supply disruptions, with Asian equities following Wall Street lower and bond yields hitting multi-decade highs amid volatility spikes. In the technology sector, a divergence is emerging. While the broader market sells off, AMD's $8.2B acquisition of World Labs signals continued aggressive consolidation in the AI infrastructure space, though the stock fell 3.6% on the news. Meanwhile, the revelation of Anthropic's $42B loss in its IPO prospectus has prompted Michael Burry to shift AI shorts to puts, highlighting growing skepticism about the profitability of frontier AI models despite massive capital expenditure. This contrasts with Eli Lilly's positive clinical data for Foundayo, which offers a defensive healthcare play against the macro headwinds. Macro-financial stress is intensifying as Treasury yields spike, prompting Treasury Secretary Scott Bessent to hire David Zervos to advise on debt strategies. The bond market volatility is raising alarms of a potential breaking point, reminiscent of 2008 signals, which compounds the pressure on growth stocks. European equities have shown slight resilience, edging up as UK shop price inflation slows, but the global sentiment remains heavily weighed down by energy costs and geopolitical uncertainty.